iBio, Inc. (NYSEMKT:IBIO)
CAPS Rating:
A bio-pharmaceutical company focused on the development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases.
A bio-pharmaceutical company focused on the development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases.
Recs
Falling back to reality after a nice surge, especially since they could be burning through their cash at to fast a rate without any great success